Cancer Immunology, Immunotherapy

, Volume 53, Issue 3, pp 234–239

Exosome-based immunotherapy

Authors

  • Nathalie Chaput
    • ERIT-M 02-08 INSERM, Department of Clinical BiologyInstitut Gustave Roussy (IGR)
  • Julien Taïeb
    • ERIT-M 02-08 INSERM, Department of Clinical BiologyInstitut Gustave Roussy (IGR)
    • Department of Hepatology and GastroenterologyPitié Salpétrière Hospital
  • Noël E. C. Schartz
    • ERIT-M 02-08 INSERM, Department of Clinical BiologyInstitut Gustave Roussy (IGR)
    • Department of DermatologySaint Louis Hospital
  • Fabrice André
    • ERIT-M 02-08 INSERM, Department of Clinical BiologyInstitut Gustave Roussy (IGR)
    • Department of Medical OncologyInstitut Gustave Roussy (IGR)
  • Eric Angevin
    • ERIT-M 02-08 INSERM, Department of Clinical BiologyInstitut Gustave Roussy (IGR)
    • ERIT-M 02-08 INSERM, Department of Clinical BiologyInstitut Gustave Roussy (IGR)
Review

DOI: 10.1007/s00262-003-0472-x

Cite this article as:
Chaput, N., Taïeb, J., Schartz, N.E.C. et al. Cancer Immunol Immunother (2004) 53: 234. doi:10.1007/s00262-003-0472-x

Abstract

Exosomes are small membrane vesicles originating from late endosomes and secreted by hematopoietic and epithelial cells in culture. Exosome proteic and lipid composition is unique and might shed some light into exosome biogenesis and function. Exosomes secreted from professional antigen-presenting cells (i.e., B lymphocytes and dendritic cells) are enriched in MHC class I and II complexes, costimulatory molecules, and hsp70–90 chaperones, and have therefore been more extensively studied for their immunomodulatory capacities in vitro and in vivo. This review will present the main biological features pertaining to tumor or DC-derived exosomes, will emphasize their immunostimulatory function, and will discuss their implementation in cancer immunotherapy.

Keywords

ExosomesCross-presentationMHC complexesTumorImmunotherapy

Abbreviations

APC

antigen-presenting cell

ASI

active specific immunotherapy

CTL

cytotoxic T lymphocyte

DC

dendritic cell

FDC

follicular dendritic cell

MD-DC

monocyte-derived dendritic cell

GMP

good manufacturing procedure

HLA

human leukocyte antigen

HSP

heat shock protein

MHC

major histocompatibility complex

MVB

multivesicular body

ExAs

ascitis-derived exosomes

DEX

DC-derived exosome

TEX

tumor cell–derived exosome

Copyright information

© Springer-Verlag 2004